A detailed history of Ferguson Wellman Capital Management, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Ferguson Wellman Capital Management, Inc holds 228,429 shares of ABT stock, worth $29.2 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
228,429
Previous 234,769 2.7%
Holding current value
$29.2 Million
Previous $26.8 Million 3.47%
% of portfolio
0.51%
Previous 0.54%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

SELL
$111.93 - $119.39 $709,636 - $756,932
-6,340 Reduced 2.7%
228,429 $25.8 Million
Q3 2024

Nov 06, 2024

BUY
$100.07 - $118.13 $2.07 Million - $2.44 Million
20,680 Added 9.66%
234,769 $26.8 Million
Q3 2024

Oct 18, 2024

SELL
$100.07 - $118.13 $26.2 Million - $31 Million
-262,042 Reduced 55.04%
214,089 $24.4 Million
Q2 2024

Jul 16, 2024

SELL
$100.73 - $112.44 $293,829 - $327,987
-2,917 Reduced 0.61%
476,131 $49.5 Million
Q1 2024

Apr 09, 2024

BUY
$109.52 - $120.96 $1.08 Million - $1.19 Million
9,834 Added 2.1%
479,048 $54.4 Million
Q4 2023

Jan 11, 2024

BUY
$90.19 - $110.4 $972,879 - $1.19 Million
10,787 Added 2.35%
469,214 $51.6 Million
Q3 2023

Oct 12, 2023

BUY
$95.53 - $114.62 $5.36 Million - $6.43 Million
56,062 Added 13.93%
458,427 $44.4 Million
Q2 2023

Jul 11, 2023

BUY
$100.78 - $112.29 $790,820 - $881,139
7,847 Added 1.99%
402,365 $43.9 Million
Q1 2023

Apr 20, 2023

BUY
$96.86 - $114.01 $4.96 Million - $5.84 Million
51,217 Added 14.92%
394,518 $39.9 Million
Q4 2022

Jan 13, 2023

BUY
$95.06 - $111.52 $13.5 Million - $15.8 Million
141,684 Added 70.27%
343,301 $37.7 Million
Q3 2022

Oct 17, 2022

SELL
$96.76 - $112.03 $5.63 Million - $6.52 Million
-58,182 Reduced 22.4%
201,617 $19.5 Million
Q2 2022

Jul 14, 2022

BUY
$102.07 - $123.37 $12.6 Million - $15.2 Million
123,162 Added 90.14%
259,799 $28.2 Million
Q1 2022

Apr 14, 2022

SELL
$114.02 - $139.04 $238,187 - $290,454
-2,089 Reduced 1.51%
136,637 $16.2 Million
Q4 2021

Jan 10, 2022

BUY
$115.53 - $141.46 $10.5 Million - $12.9 Million
91,307 Added 192.55%
138,726 $19.5 Million
Q3 2021

Oct 22, 2021

BUY
$116.66 - $129.06 $141,158 - $156,162
1,210 Added 2.62%
47,419 $5.6 Million
Q2 2021

Jul 12, 2021

SELL
$105.79 - $124.53 $19,253 - $22,664
-182 Reduced 0.39%
46,209 $5.36 Million
Q1 2021

Apr 26, 2021

SELL
$108.84 - $128.23 $35,155 - $41,418
-323 Reduced 0.69%
46,391 $5.56 Million
Q4 2020

Feb 04, 2021

SELL
$105.0 - $114.42 $194,250 - $211,677
-1,850 Reduced 3.81%
46,714 $5.12 Million
Q3 2020

Oct 13, 2020

SELL
$91.64 - $111.29 $94,939 - $115,296
-1,036 Reduced 2.09%
48,564 $5.29 Million
Q2 2020

Aug 04, 2020

SELL
$76.57 - $98.0 $59,954 - $76,734
-783 Reduced 1.55%
49,600 $4.54 Million
Q1 2020

Apr 21, 2020

SELL
$62.82 - $91.86 $116,656 - $170,584
-1,857 Reduced 3.55%
50,383 $3.98 Million
Q4 2019

Jan 24, 2020

BUY
$78.51 - $87.4 $144,929 - $161,340
1,846 Added 3.66%
52,240 $4.54 Million
Q3 2019

Oct 15, 2019

SELL
$81.84 - $88.74 $112,038 - $121,485
-1,369 Reduced 2.64%
50,394 $4.22 Million
Q2 2019

Jul 16, 2019

SELL
$72.88 - $85.0 $39,355 - $45,900
-540 Reduced 1.03%
51,763 $4.35 Million
Q1 2019

Apr 11, 2019

BUY
$66.22 - $80.06 $15,230 - $18,413
230 Added 0.44%
52,303 $4.18 Million
Q4 2018

Jan 16, 2019

SELL
$65.56 - $74.27 $186,452 - $211,223
-2,844 Reduced 5.18%
52,073 $3.77 Million
Q3 2018

Oct 25, 2018

SELL
$60.81 - $73.36 $50,229 - $60,595
-826 Reduced 1.48%
54,917 $4.03 Million
Q2 2018

Aug 10, 2018

SELL
$57.57 - $63.54 $6,678 - $7,370
-116 Reduced 0.21%
55,743 $3.4 Million
Q1 2018

Apr 09, 2018

BUY
$56.27 - $63.62 $55,144 - $62,347
980 Added 1.79%
55,859 $3.35 Million
Q4 2017

Jan 24, 2018

SELL
$53.68 - $57.47 $5,260 - $5,632
-98 Reduced 0.18%
54,879 $3.13 Million
Q3 2017

Oct 11, 2017

BUY
$48.06 - $53.64 $2.64 Million - $2.95 Million
54,977
54,977 $2.93 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $224B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Ferguson Wellman Capital Management, Inc Portfolio

Follow Ferguson Wellman Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ferguson Wellman Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ferguson Wellman Capital Management, Inc with notifications on news.